Ronna Romney’s Form 4 filings reveal a clear directional bias: she is a consistent seller of Park-Ohio Holdings (PKOH) and a recipient of recurring equity awards at Molina Healthcare (MOH), with no open-market purchases recorded across 52 transactions. The aggregate data shows $427,036.57 in total sell value against zero buy value, while $275,210.98 in acquired value stems almost entirely from compensation grants (code “A”) rather than discretionary investment. The most recent activity clusters on December 2, 2025, when she executed 17 separate PKOH sales ranging from $61.23 to $8,294.52, totaling roughly $51,000 in a single day—a pattern consistent with a systematic liquidation of a position rather than a single block trade.
The selling bias is concentrated in PKOH, where her trades include small, fragmented sales on March 12, 2026 ($2,259 and $46,756.80) and a December 2025 burst of 15 transactions. By contrast, her MOH activity is dominated by quarterly grants: $55,114.35 on July 1, 2026, $55,007.10 on April 1, 2026, $55,012.18 on January 1, 2026, and $54,945.15 on October 1, 2025—each roughly $55,000, indicating a regular compensation schedule. The only MOH sale appears on March 12, 2026, at $74,341.52, which, alongside the PKOH sales that same date, suggests a coordinated disposition event.
Over the trailing 12 months, the pattern is unambiguous: 20 recent sales, zero purchases, and no option exercises or tax-withholding transactions (codes “M” or “F”) in the visible data. The absence of open-market buys (code “P”) across all 52 filings underscores that Romney’s equity activity is passive—she monetizes PKOH holdings while accumulating MOH stock solely through board compensation. The dollar-weighted direction is firmly negative, with total sell value exceeding total acquired value by roughly $152,000, and the recent cluster of PKOH sales indicates an ongoing reduction of that position.
AI-assisted summary